Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages
暂无分享,去创建一个
O. Francone | L. Royer | T. Coskran | D. Brees | S. Lindsey | P. Bourassa | R. Aiello | M. Haghpassand | Timothy M. Coskran
[1] R. F. Hoyt,et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Brewer,et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. , 2001, The Journal of clinical investigation.
[3] T. Hudson,et al. Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease , 2001, Circulation.
[4] J. Oram. Novel approaches to treating cardiovascular disease: lessons from Tangier disease , 2001, Expert opinion on investigational drugs.
[5] A. Beaudet,et al. Absence of P-Selectin, but Not Intercellular Adhesion Molecule-1, Attenuates Neointimal Growth After Arterial Injury in Apolipoprotein E–Deficient Mice , 2001, Circulation.
[6] A. Rzhetsky,et al. The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.
[7] M. Jaye,et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. , 2000, Nature medicine.
[8] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[9] O. Francone,et al. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.
[10] R. Evans,et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. , 2001, Molecular cell.
[11] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[12] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Mcneish,et al. The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.
[14] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[15] R. Lawn,et al. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. , 2000, Biochemical and biophysical research communications.
[16] S. Zuckerman,et al. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[17] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] Robert V Farese,et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. , 2000, The Journal of clinical investigation.
[19] G. Schmitz,et al. ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? , 2000, Pathobiology.
[20] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[21] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[22] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[23] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[24] O. Quehenberger,et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[25] A Rubartelli,et al. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.
[26] B. Verrier,et al. ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.
[27] P. Milos,et al. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Luciani,et al. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. , 1996, The EMBO journal.
[29] A. Attie,et al. Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[30] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[31] M. E. Cook,et al. High density lipoprotein deficiency syndrome in chickens is not associated with an increased susceptibility to atherosclerosis. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[32] R. Gerrity,et al. Evidence for an altered lipid metabolic state in circulating blood monocytes under conditions of hyperlipemia in swine and its implications in arterial lipid metabolism. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[33] D. Gordon,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.
[34] E. Schaefer. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.
[35] C. Blum,et al. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. , 1978, The New England journal of medicine.
[36] D. Fredrickson,et al. β-Sitosterolemia and Xanthomatosis , 1976 .
[37] W. Connor,et al. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. , 1974, The Journal of clinical investigation.
[38] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.